“There was some debate about IVUS many years ago, but then randomized controlled trials came out, as well as other observational studies, to show that it is effective in optimizing post-PCI results, ...
Arterial and deep venous disease are on the rise: more than 21 million people in the U.S. had peripheral arterial disease (PAD) in 2020, a number that’s expected to rise to 24 million by 2030, while ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Evident Vascular, Inc., a medical technology startup developing a next-generation intravascular ultrasound (IVUS) platform leveraging artificial intelligence to ...
Photo Credit: Prati F. When IVUS-OCT Guidance is a Need: Highly Calcified Lesions and ACS. Presented at TCT 2019. September 26, 2019. A three-way comparison of PCI guidance confirms that, when sizing ...
Funding to accelerate development of next-generation intravascular ultrasound platform and support FDA clearance for U.S. market launch SAN JOSE, Calif.–(BUSINESS WIRE)–March 25, 2025– Evident ...
Evident Vascular, a company creating AI-enabled intravascular ultrasound technology, announced its launch today with $35 million in Series A financing. Vensana Capital led the round. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results